Obligations de LLYCL
Voici la liste des obligations d'entreprise de ELI LILLY AND COMPANY . Les investisseurs optent souvent pour les obligations d'une société en raison de leur stabilité accrue en période de volatilité du marché. Étudiez les prix, les rendements et d'autres statistiques et trouvez un investissement fiable.
Symbole | YTM % | Prix % | Coupon % | Date d'échéance | Montant en suspens | Valeur nominale | Montant min de la dénomination | Émetteur |
|---|---|---|---|---|---|---|---|---|
 US532457AM0ELI LILLY 2025 | 5,71% | 101,38% | 7,13% | 2025-06-01 | 217,471 M USD | 1 000,00 USD | 5 000,00 USD | Eli Lilly & Co. |
| LLY4099975Eli Lilly and Company 4.65% 15-JUN-2044 | 5,39% | 90,48% | 4,65% | 2044-06-15 | 38,336 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| LLY5871804Eli Lilly and Company 5.2% 14-AUG-2064 | 5,39% | 96,39% | 5,20% | 2064-08-14 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| LLY5547405Eli Lilly and Company 4.95% 27-FEB-2063 | 5,31% | 93,18% | 4,95% | 2063-02-27 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| LLY5871803Eli Lilly and Company 5.05% 14-AUG-2054 | 5,30% | 95,81% | 5,05% | 2054-08-14 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| LLY5547404Eli Lilly and Company 4.875% 27-FEB-2053 | 5,30% | 93,17% | 4,88% | 2053-02-27 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| LLY5750032Eli Lilly and Company 5.1% 09-FEB-2064 | 5,29% | 96,37% | 5,10% | 2064-02-09 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| LLY.GGEli Lilly and Company 6.77% 01-JAN-2036 | 5,24% | 113,25% | 6,77% | 2036-01-01 | 158,565 M USD | 1 000,00 USD | 1 000,00 USD | Eli Lilly & Co. |
| LLY5750031Eli Lilly and Company 5.0% 09-FEB-2054 | 5,21% | 96,55% | 5,00% | 2054-02-09 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| US532457BS6ELI LILLY 19/39 | 5,17% | 86,41% | 3,88% | 2039-03-15 | 240,253 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| US532457BT4ELI LILLY 19/49 | 5,13% | 82,27% | 3,95% | 2049-03-15 | 958,153 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| US532457BU1ELI LILLY 19/59 | 5,11% | 82,41% | 4,15% | 2059-03-15 | 591,286 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| LLY4217068Eli Lilly and Company 3.7% 01-MAR-2045 | 5,10% | 81,27% | 3,70% | 2045-03-01 | 386,799 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| LLY4492882Eli Lilly and Company 3.95% 15-MAY-2047 | 5,08% | 83,83% | 3,95% | 2047-05-15 | 346,952 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| LLY5547406Eli Lilly and Company 5.0% 27-FEB-2026 | 5,07% | 99,91% | 5,00% | 2026-02-27 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| XS238628644ELI LILLY 21/43 | 5,04% | 56,29% | 1,63% | 2043-09-14 | 250 M GBP | 1 000,00 GBP | 100 000,00 GBP | Eli Lilly & Co. |
| LLY.HWEli Lilly and Company 5.95% 15-NOV-2037 | 5,04% | 108,95% | 5,95% | 2037-11-15 | 266,828 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| LLY.GWEli Lilly and Company 5.55% 15-MAR-2037 | 4,98% | 105,37% | 5,55% | 2037-03-15 | 444,732 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| LLY5750405Eli Lilly and Company 4.7% 09-FEB-2034 | 4,96% | 98,01% | 4,70% | 2034-02-09 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| LLY5871807Eli Lilly and Company 4.6% 14-AUG-2034 | 4,96% | 97,20% | 4,60% | 2034-08-14 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| US532457BY3ELI LILLY 20/50 | 4,87% | 58,72% | 2,25% | 2050-05-15 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| LLY5546986Eli Lilly and Company 4.7% 27-FEB-2033 | 4,84% | 99,01% | 4,70% | 2033-02-27 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| US532457BZ0ELI LILLY 20/60 | 4,76% | 56,29% | 2,50% | 2060-09-15 | 850 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| LLY5871810Eli Lilly and Company 4.2% 14-AUG-2029 | 4,54% | 98,51% | 4,20% | 2029-08-14 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| LLY5750404Eli Lilly and Company 4.5% 09-FEB-2029 | 4,51% | 99,95% | 4,50% | 2029-02-09 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| US532457BV9ELI LILLY 19/29 | 4,51% | 95,49% | 3,38% | 2029-03-15 | 930,564 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| LLY5750407Eli Lilly and Company 4.5% 09-FEB-2027 | 4,42% | 100,18% | 4,50% | 2027-02-09 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| LLY5871809Eli Lilly and Company 4.15% 14-AUG-2027 | 4,35% | 99,48% | 4,15% | 2027-08-14 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| LLY4492876Eli Lilly and Company 3.1% 15-MAY-2027 | 4,30% | 97,11% | 3,10% | 2027-05-15 | 401,45 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| LLY.GVEli Lilly and Company 5.5% 15-MAR-2027 | 4,19% | 102,95% | 5,50% | 2027-03-15 | 364,324 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| LLYCELI LILLY 15/25 | 3,99% | 98,78% | 2,75% | 2025-06-01 | 560,646 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |
| XS207593800ELI LILLY 19/49 | 3,27% | 72,14% | 1,70% | 2049-11-01 | 1 B EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. |
| XS238622069ELI LILLY 21/61 | 3,27% | 56,43% | 1,38% | 2061-09-14 | 700 M EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. |
| XS238618657ELI LILLY 21/51 | 3,20% | 61,02% | 1,13% | 2051-09-14 | 500 M EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. |
| XS238618606ELI LILLY 21/33 | 2,89% | 81,24% | 0,50% | 2033-09-14 | 600 M EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. |
| XS207593737ELI LILLY 19/31 | 2,88% | 85,67% | 0,63% | 2031-11-01 | 600 M EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. |
| XS124075122ELI LILLY 15/30 | 2,79% | 96,53% | 2,13% | 2030-06-03 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. |
| LLYFELI LILLY 15/26 | 2,64% | 98,43% | 1,63% | 2026-06-02 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. |
| CH32373560ELI LILLY 16-28 | 0,57% | 99,58% | 0,45% | 2028-05-24 | 400 M CHF | 5 000,00 CHF | 5 000,00 CHF | Eli Lilly & Co. |